BIOMARIN PHARMACEUTICAL INC Operating Income
BIOMARIN PHARMACEUTICAL INC (BMRN) reported Operating Income of $110.92 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Income Statement
us-gaap:OperatingIncomeLoss · last filed 2026-08-06
- BIOMARIN PHARMACEUTICAL INC operating income (loss) for the quarter ending 2026-06-30 was $110.92M, a 59.94% decline year-over-year.
- BIOMARIN PHARMACEUTICAL INC operating income (loss) for the quarter ending 2026-03-31 was $129.64M, a 42.10% decline year-over-year.
- BIOMARIN PHARMACEUTICAL INC operating income (loss) for the quarter ending 2025-12-31 was -$44.61M, a 127.64% decline year-over-year.
- BIOMARIN PHARMACEUTICAL INC operating income (loss) for the quarter ending 2025-09-30 was -$46.69M, a 141.00% decline year-over-year.
- BIOMARIN PHARMACEUTICAL INC operating income (loss) for fiscal 2025 was $409.48M, a 15.43% decline from fiscal 2024.
- BIOMARIN PHARMACEUTICAL INC operating income (loss) for fiscal 2024 was $484.21M, a 160.65% increase from fiscal 2023.
- BIOMARIN PHARMACEUTICAL INC operating income (loss) for fiscal 2023 was $185.77M, a 15.41% increase from fiscal 2022.
- BIOMARIN PHARMACEUTICAL INC operating income (loss) for fiscal 2022 was $160.97M.
| Period end | Operating Income (Loss) 3 month | Operating Income (Loss) 3 month as first filed | Operating Income (Loss) 6 month | Operating Income (Loss) 6 month as first filed | Operating Income (Loss) 9 month | Operating Income (Loss) 9 month as first filed | Operating Income (Loss) 12 month | Operating Income (Loss) 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $110.92M 10-Q · filed 2026-08-06 | $240.56M 10-Q · filed 2026-08-06 | $195.95M derived: sum of 3 quarters · filed 2026-08-06 | $149.26M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2026-03-31 | $129.64M 10-Q · filed 2026-05-05 | $85.03M derived: sum of 2 quarters · filed 2026-05-05 | $38.34M derived: sum of 3 quarters · filed 2026-05-05 | $315.23M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-12-31 | -$44.61M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$91.30M derived: sum of 2 quarters · filed 2026-02-26 | $185.59M derived: sum of 3 quarters · filed 2026-08-06 | $409.48M 10-K · filed 2026-02-26 | ||||
| 2025-09-30 | -$46.69M 10-Q · filed 2025-10-28 | $230.19M derived: sum of 2 quarters · filed 2026-08-06 | $454.09M 10-Q · filed 2025-10-28 | $615.50M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-06-30 | $276.89M 10-Q · filed 2026-08-06 | $500.78M 10-Q · filed 2026-08-06 | $662.19M derived: sum of 3 quarters · filed 2026-08-06 | $776.08M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-03-31 | $223.89M 10-Q · filed 2026-05-05 | $385.30M derived: sum of 2 quarters · filed 2026-05-05 | $499.19M derived: sum of 3 quarters · filed 2026-05-05 | $619.64M derived: sum of 4 quarters · filed 2026-05-05 | ||||
| 2024-12-31 | $161.41M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $275.30M derived: sum of 2 quarters · filed 2026-02-26 | $395.75M derived: sum of 3 quarters · filed 2026-02-26 | $484.21M 10-K · filed 2026-02-26 | ||||
| 2024-09-30 | $113.89M 10-Q · filed 2025-10-28 | $234.34M derived: sum of 2 quarters · filed 2025-10-28 | $322.81M 10-Q · filed 2025-10-28 | $350.09M derived: sum of 4 quarters · filed 2026-02-26 | ||||
| 2024-06-30 | $120.45M 10-Q · filed 2025-08-05 | $208.91M 10-Q · filed 2025-08-05 | $236.19M derived: sum of 3 quarters · filed 2026-02-26 | $266.72M derived: sum of 4 quarters · filed 2026-02-26 | ||||
| 2024-03-31 | $88.46M 10-Q · filed 2025-05-02 | $115.74M derived: sum of 2 quarters · filed 2026-02-26 | $146.27M derived: sum of 3 quarters · filed 2026-02-26 | $211.83M derived: sum of 4 quarters · filed 2026-02-26 | ||||
| 2023-12-31 | $27.28M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $57.80M derived: sum of 2 quarters · filed 2026-02-26 | $123.37M derived: sum of 3 quarters · filed 2026-02-26 | $185.77M 10-K · filed 2026-02-26 | $158.10M 10-K · filed 2024-02-26 | |||
| 2023-09-30 | $30.52M 10-Q · filed 2024-10-31 | $25.66M 10-Q · filed 2023-11-02 | $96.09M derived: sum of 2 quarters · filed 2024-10-31 | $158.50M 10-Q · filed 2024-10-31 | $143.88M 10-Q · filed 2023-11-02 | $145.41M derived: sum of 4 quarters · filed 2025-02-24 | ||
| 2023-06-30 | $65.57M 10-Q · filed 2024-08-05 | $58.87M 10-Q · filed 2023-08-02 | $127.97M 10-Q · filed 2024-08-05 | $118.22M 10-Q · filed 2023-08-02 | $114.88M derived: sum of 3 quarters · filed 2025-02-24 | $112.47M derived: sum of 4 quarters · filed 2025-02-24 | ||
| 2023-03-31 | $62.40M 10-Q · filed 2024-04-26 | $59.35M 10-Q · filed 2023-04-28 | $49.32M derived: sum of 2 quarters · filed 2025-02-24 | $46.90M derived: sum of 3 quarters · filed 2025-02-24 | $86.05M derived: sum of 4 quarters · filed 2025-02-24 | |||
| 2022-12-31 | -$13.09M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-24 | -$15.51M derived: sum of 2 quarters · filed 2025-02-24 | $23.65M derived: sum of 3 quarters · filed 2025-02-24 | $160.97M 10-K · filed 2025-02-24 | $149.56M 10-K · filed 2023-02-27 | |||
| 2022-09-30 | -$2.42M 10-Q · filed 2023-11-02 | $36.73M derived: sum of 2 quarters · filed 2023-11-02 | $174.06M 10-Q · filed 2023-11-02 | $108.18M derived: sum of 4 quarters · filed 2024-02-26 | ||||
| 2022-06-30 | $39.15M 10-Q · filed 2023-08-02 | $176.48M 10-Q · filed 2023-08-02 | $110.60M derived: sum of 3 quarters · filed 2024-02-26 | $57.38M derived: sum of 4 quarters · filed 2024-02-26 | ||||
| 2022-03-31 | $137.33M 10-Q · filed 2023-04-28 | $71.45M derived: sum of 2 quarters · filed 2024-02-26 | $18.23M derived: sum of 3 quarters · filed 2024-02-26 | $29.90M derived: sum of 4 quarters · filed 2024-02-26 | ||||
| 2021-12-31 | -$65.88M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-26 | -$119.10M derived: sum of 2 quarters · filed 2024-02-26 | -$107.43M derived: sum of 3 quarters · filed 2024-02-26 | -$82.34M 10-K · filed 2024-02-26 | ||||
| 2021-09-30 | -$53.22M 10-Q · filed 2022-10-28 | -$41.55M derived: sum of 2 quarters · filed 2022-10-28 | -$16.46M 10-Q · filed 2022-10-28 | -$67.98M derived: sum of 4 quarters · filed 2023-02-27 | ||||
| 2021-06-30 | $11.67M 10-Q · filed 2022-08-04 | $36.76M 10-Q · filed 2022-08-04 | -$14.76M derived: sum of 3 quarters · filed 2023-02-27 | -$70.70M derived: sum of 4 quarters · filed 2023-02-27 | ||||
| 2021-03-31 | $25.09M 10-Q · filed 2022-04-29 | -$26.43M derived: sum of 2 quarters · filed 2023-02-27 | -$82.37M derived: sum of 3 quarters · filed 2023-02-27 | -$123.31M derived: sum of 4 quarters · filed 2023-02-27 | ||||
| 2020-12-31 | -$51.52M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-27 | -$107.46M derived: sum of 2 quarters · filed 2023-02-27 | -$148.40M derived: sum of 3 quarters · filed 2023-02-27 | -$43.44M 10-K · filed 2023-02-27 | -$36.77M 10-K · filed 2021-02-26 | |||
| 2020-09-30 | -$55.94M 10-Q · filed 2021-10-29 | -$96.89M derived: sum of 2 quarters · filed 2021-10-29 | $8.07M 10-Q · filed 2021-10-29 | -$1.09M derived: sum of 4 quarters · filed 2022-02-25 | ||||
| 2020-06-30 | -$40.95M 10-Q · filed 2021-07-30 | $64.02M 10-Q · filed 2021-07-30 | $54.85M derived: sum of 3 quarters · filed 2022-02-25 | $58.86M derived: sum of 4 quarters · filed 2022-02-25 | ||||
| 2020-03-31 | $104.96M 10-Q · filed 2021-04-30 | $95.80M derived: sum of 2 quarters · filed 2022-02-25 | $99.81M derived: sum of 3 quarters · filed 2022-02-25 | $58.45M derived: sum of 4 quarters · filed 2022-02-25 | ||||
| 2019-12-31 | -$9.16M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-25 | -$5.15M derived: sum of 2 quarters · filed 2022-02-25 | -$46.51M derived: sum of 3 quarters · filed 2022-02-25 | -$100.46M 10-K · filed 2022-02-25 | ||||
| 2019-09-30 | $4.01M 10-Q · filed 2020-11-06 | -$37.34M derived: sum of 2 quarters · filed 2020-11-06 | -$91.30M 10-Q · filed 2020-11-06 | -$129.44M derived: sum of 4 quarters · filed 2021-02-26 | ||||
| 2019-06-30 | -$41.35M 10-Q · filed 2020-08-05 | -$95.31M 10-Q · filed 2020-08-05 | -$133.45M derived: sum of 3 quarters · filed 2021-02-26 | -$149.19M derived: sum of 4 quarters · filed 2021-02-26 | ||||
| 2019-03-31 | -$53.95M 10-Q · filed 2020-05-01 | -$92.10M derived: sum of 2 quarters · filed 2021-02-26 | -$107.84M derived: sum of 3 quarters · filed 2021-02-26 | -$133.10M derived: sum of 4 quarters · filed 2021-02-26 | ||||
| 2018-12-31 | -$38.15M derived: 10-K 12 month − 10-Q/A 9 month · filed 2021-02-26 | -$53.89M derived: sum of 2 quarters · filed 2021-02-26 | -$79.15M derived: sum of 3 quarters · filed 2021-02-26 | -$123.52M 10-K · filed 2021-02-26 | ||||
| 2018-09-30 | -$15.74M 10-Q/A · filed 2019-11-04 | -$41.00M derived: sum of 2 quarters · filed 2019-11-04 | -$85.38M 10-Q/A · filed 2019-11-04 | -$27.33M derived: sum of 4 quarters · filed 2020-02-27 | ||||
| 2018-06-30 | -$25.26M 10-Q · filed 2019-08-02 | -$69.64M 10-Q · filed 2019-08-02 | -$11.59M derived: sum of 3 quarters · filed 2020-02-27 | -$25.32M derived: sum of 4 quarters · filed 2020-02-27 | ||||
| 2018-03-31 | -$44.37M 10-Q · filed 2019-04-29 | $13.68M derived: sum of 2 quarters · filed 2020-02-27 | -$52.00K derived: sum of 3 quarters · filed 2020-02-27 | -$38.86M derived: sum of 4 quarters · filed 2020-02-27 | ||||
| 2017-12-31 | $58.05M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-27 | $44.32M derived: sum of 2 quarters · filed 2020-02-27 | $5.51M derived: sum of 3 quarters · filed 2020-02-27 | -$14.70M 10-K · filed 2020-02-27 | ||||
| 2017-09-30 | -$13.73M 10-Q · filed 2018-10-26 | -$52.54M derived: sum of 2 quarters · filed 2018-10-26 | -$72.75M 10-Q · filed 2018-10-26 | -$162.37M derived: sum of 4 quarters · filed 2019-02-28 | ||||
| 2017-06-30 | -$38.81M 10-Q · filed 2018-08-03 | -$59.02M 10-Q · filed 2018-08-03 | -$148.64M derived: sum of 3 quarters · filed 2019-02-28 | -$208.73M derived: sum of 4 quarters · filed 2019-02-28 | ||||
| 2017-03-31 | -$20.21M 10-Q · filed 2018-04-27 | -$109.83M derived: sum of 2 quarters · filed 2019-02-28 | -$169.91M derived: sum of 3 quarters · filed 2019-02-28 | -$742.72M derived: sum of 4 quarters · filed 2019-02-28 | ||||
| 2016-12-31 | -$89.62M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-28 | -$149.71M derived: sum of 2 quarters · filed 2019-02-28 | -$722.51M derived: sum of 3 quarters · filed 2019-02-28 | -$803.43M 10-K · filed 2019-02-28 | ||||
| 2016-09-30 | -$60.09M 10-Q · filed 2017-10-31 | -$632.89M derived: sum of 2 quarters · filed 2017-10-31 | -$713.81M 10-Q · filed 2017-10-31 | -$612.49M derived: sum of 4 quarters · filed 2018-02-26 | ||||
| 2016-06-30 | -$572.81M 10-Q · filed 2017-08-02 | -$653.72M 10-Q · filed 2017-08-02 | -$552.40M derived: sum of 3 quarters · filed 2018-02-26 | -$634.28M derived: sum of 4 quarters · filed 2018-02-26 | ||||
| 2016-03-31 | -$80.92M 10-Q · filed 2017-05-04 | $20.40M derived: sum of 2 quarters · filed 2018-02-26 | -$61.47M derived: sum of 3 quarters · filed 2018-02-26 | -$125.76M derived: sum of 4 quarters · filed 2018-02-26 | ||||
| 2015-12-31 | $101.32M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-26 | $19.45M derived: sum of 2 quarters · filed 2018-02-26 | -$44.84M derived: sum of 3 quarters · filed 2018-02-26 | -$110.70M 10-K · filed 2018-02-26 | ||||
| 2015-09-30 | -$81.87M 10-Q · filed 2016-11-03 | -$146.16M derived: sum of 2 quarters · filed 2016-11-03 | -$212.02M 10-Q · filed 2016-11-03 | -$270.78M derived: sum of 4 quarters · filed 2017-02-27 | ||||
| 2015-06-30 | -$64.29M 10-Q · filed 2016-08-08 | -$64.24M 10-Q · filed 2015-08-05 | -$130.15M 10-Q · filed 2016-08-08 | -$130.10M 10-Q · filed 2015-08-05 | -$188.90M derived: sum of 3 quarters · filed 2017-02-27 | -$177.70M derived: sum of 4 quarters · filed 2017-02-27 | ||
| 2015-03-31 | -$65.86M 10-Q · filed 2016-05-02 | -$124.62M derived: sum of 2 quarters · filed 2017-02-27 | -$113.41M derived: sum of 3 quarters · filed 2017-02-27 | -$132.29M derived: sum of 4 quarters · filed 2017-02-27 | ||||
| 2014-12-31 | -$58.76M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-27 | -$47.55M derived: sum of 2 quarters · filed 2017-02-27 | -$66.44M derived: sum of 3 quarters · filed 2017-02-27 | -$92.89M 10-K · filed 2017-02-27 | ||||
| 2014-09-30 | $11.20M 10-Q · filed 2015-11-02 | -$7.68M derived: sum of 2 quarters · filed 2015-11-02 | -$34.13M 10-Q · filed 2015-11-02 | -$86.44M derived: sum of 4 quarters · filed 2016-02-29 | ||||
| 2014-06-30 | -$18.88M 10-Q · filed 2015-08-05 | -$45.34M 10-Q · filed 2015-08-05 | -$97.65M derived: sum of 3 quarters · filed 2016-02-29 | -$148.37M derived: sum of 4 quarters · filed 2016-02-29 | ||||
| 2014-03-31 | -$26.46M 10-Q · filed 2015-05-05 | -$78.77M derived: sum of 2 quarters · filed 2016-02-29 | -$129.49M derived: sum of 3 quarters · filed 2016-02-29 | -$149.54M derived: sum of 4 quarters · filed 2016-02-29 | ||||
| 2013-12-31 | -$52.31M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-29 | -$103.03M derived: sum of 2 quarters · filed 2016-02-29 | -$123.09M derived: sum of 3 quarters · filed 2016-02-29 | -$156.01M 10-K · filed 2016-02-29 | ||||
| 2013-09-30 | -$50.72M 10-Q · filed 2014-10-28 | -$70.78M derived: sum of 2 quarters · filed 2014-10-28 | -$103.70M 10-Q · filed 2014-10-28 | -$150.60M derived: sum of 4 quarters · filed 2015-03-02 | ||||
| 2013-06-30 | -$20.05M 10-Q · filed 2014-07-31 | -$52.97M 10-Q · filed 2014-07-31 | -$99.88M derived: sum of 3 quarters · filed 2015-03-02 | -$110.37M derived: sum of 4 quarters · filed 2015-03-02 | ||||
| 2013-03-31 | -$32.92M 10-Q · filed 2014-05-02 | -$79.83M derived: sum of 2 quarters · filed 2015-03-02 | -$90.32M derived: sum of 3 quarters · filed 2015-03-02 | -$121.27M derived: sum of 4 quarters · filed 2015-03-02 | ||||
| 2012-12-31 | -$46.90M derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-02 | -$57.40M derived: sum of 2 quarters · filed 2015-03-02 | -$88.35M derived: sum of 3 quarters · filed 2015-03-02 | -$110.22M 10-K · filed 2015-03-02 | ||||
| 2012-09-30 | -$10.49M 10-Q · filed 2013-10-28 | -$41.45M derived: sum of 2 quarters · filed 2013-10-28 | -$63.31M 10-Q · filed 2013-10-28 | -$84.75M derived: sum of 4 quarters · filed 2014-02-26 | ||||
| 2012-06-30 | -$30.95M 10-Q · filed 2013-07-29 | -$52.82M 10-Q · filed 2013-07-29 | -$74.25M derived: sum of 3 quarters · filed 2014-02-26 | -$89.77M derived: sum of 4 quarters · filed 2014-02-26 | ||||
| 2012-03-31 | -$21.87M 10-Q · filed 2013-04-29 | -$43.30M derived: sum of 2 quarters · filed 2014-02-26 | -$58.82M derived: sum of 3 quarters · filed 2014-02-26 | -$58.05M derived: sum of 4 quarters · filed 2014-02-26 | ||||
| 2011-12-31 | -$21.43M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-26 | -$36.95M derived: sum of 2 quarters · filed 2014-02-26 | -$36.18M derived: sum of 3 quarters · filed 2014-02-26 | -$33.89M 10-K · filed 2014-02-26 | ||||
| 2011-09-30 | -$15.52M 10-Q · filed 2012-10-29 | -$14.75M derived: sum of 2 quarters · filed 2012-10-29 | -$12.46M 10-Q · filed 2012-10-29 | -$15.80M derived: sum of 4 quarters · filed 2013-02-26 | ||||
| 2011-06-30 | $768.00K 10-Q · filed 2012-08-02 | $3.06M 10-Q · filed 2012-08-02 | -$288.00K derived: sum of 3 quarters · filed 2013-02-26 | -$2.23M derived: sum of 4 quarters · filed 2013-02-26 | ||||
| 2011-03-31 | $2.29M 10-Q · filed 2012-04-30 | -$1.06M derived: sum of 2 quarters · filed 2013-02-26 | -$3.00M derived: sum of 3 quarters · filed 2013-02-26 | $48.00K derived: sum of 4 quarters · filed 2013-02-26 | ||||
| 2010-12-31 | -$3.35M derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-26 | -$5.29M derived: sum of 2 quarters · filed 2013-02-26 | -$2.25M derived: sum of 3 quarters · filed 2013-02-26 | $544.00K 10-K · filed 2013-02-26 | ||||
| 2010-09-30 | -$1.94M 10-Q · filed 2011-10-31 | $1.10M derived: sum of 2 quarters · filed 2011-10-31 | $3.89M 10-Q · filed 2011-10-31 | $10.28M derived: sum of 4 quarters · filed 2012-02-22 | ||||
| 2010-06-30 | $3.04M 10-Q · filed 2011-08-01 | $5.83M 10-Q · filed 2011-08-01 | $12.21M derived: sum of 3 quarters · filed 2012-02-22 | $22.35M derived: sum of 4 quarters · filed 2012-02-22 | ||||
| 2010-03-31 | $2.79M 10-Q · filed 2011-04-29 | $9.17M derived: sum of 2 quarters · filed 2012-02-22 | $19.30M derived: sum of 3 quarters · filed 2012-02-22 | $23.62M derived: sum of 4 quarters · filed 2012-02-22 | ||||
| 2009-12-31 | $6.38M derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-22 | $16.52M derived: sum of 2 quarters · filed 2012-02-22 | $20.83M derived: sum of 3 quarters · filed 2012-02-22 | $16.43M 10-K · filed 2012-02-22 | ||||
| 2009-09-30 | $10.13M 10-Q · filed 2010-10-29 | $14.45M derived: sum of 2 quarters · filed 2010-10-29 | $10.04M 10-Q · filed 2010-10-29 | |||||
| 2009-06-30 | $4.31M 10-Q · filed 2010-08-04 | -$88.00K 10-Q · filed 2010-08-04 | ||||||
| 2008-12-31 | $39.76M 10-K · filed 2011-02-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |